132 related articles for article (PubMed ID: 11102592)
1. A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring.
Weisberg E; Fraser IS; Baker J; Archer D; Landgren BM; Killick S; Soutter P; Krause T; d'Arcangues C
Contraception; 2000 Aug; 62(2):83-9. PubMed ID: 11102592
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
Bounds W; Szarewski A; Lowe D; Guillebaud J
Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
[TBL] [Abstract][Full Text] [Related]
3. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
[TBL] [Abstract][Full Text] [Related]
4. The cervico-vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring.
Roumen FJ; Boon ME; van Velzen D; Dieben TO; Coelingh Bennink HJ
Hum Reprod; 1996 Nov; 11(11):2443-8. PubMed ID: 8981130
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
[TBL] [Abstract][Full Text] [Related]
6. Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women.
Fraser IS; Lähteenmäki P; Elomaa K; Lacarra M; Mishell DR; Alvarez F; Brache V; Weisberg E; Hickey M; Vallentine P; Nash HA
Hum Reprod; 1999 Aug; 14(8):1974-8. PubMed ID: 10438412
[TBL] [Abstract][Full Text] [Related]
7. Studies of cervical caps: I. Vaginal lesions associated with use of the Vimule cap.
Bernstein GS; Kilzer LH; Coulson AH; Nakamura RM; Smith GC; Bernstein R; Frezieres R; Clark VA; Coan C
Contraception; 1982 Nov; 26(5):443-56. PubMed ID: 7160179
[TBL] [Abstract][Full Text] [Related]
8. Lea's Shield, a new barrier contraceptive preliminary clinical evaluations three-day tolerance study.
Hunt WL; Gabbay L; Potts M
Contraception; 1994 Dec; 50(6):551-61. PubMed ID: 7705097
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology associated with levonorgestrel contraception.
Misra JS; Engineer AD; Tandon P
Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
[TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
Thurman AR; Brache V; Cochon L; Ouattara LA; Chandra N; Jacot T; Yousefieh N; Clark MR; Peet M; Hanif H; Schwartz JL; Ju S; Marzinke MA; Erikson DW; Parikh U; Herold BC; Fichorova RN; Tolley E; Doncel GF
PLoS One; 2022; 17(10):e0275794. PubMed ID: 36215267
[TBL] [Abstract][Full Text] [Related]
11. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
Keller MJ; Mesquita PM; Marzinke MA; Teller R; Espinoza L; Atrio JM; Lo Y; Frank B; Srinivasan S; Fredricks DN; Rabe L; Anderson PL; Hendrix CW; Kiser PF; Herold BC
AIDS; 2016 Mar; 30(5):743-51. PubMed ID: 26605514
[TBL] [Abstract][Full Text] [Related]
12. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ
Contraception; 1992 May; 45(5):511-8. PubMed ID: 1623721
[TBL] [Abstract][Full Text] [Related]
13. Lea's Shield: a phase I postcoital study of a new contraceptive barrier device.
Archer DF; Mauck CK; Viniegra-Sibal A; Anderson FD
Contraception; 1995 Sep; 52(3):167-73. PubMed ID: 7587188
[TBL] [Abstract][Full Text] [Related]
14. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of a female condom on the female lower genital tract.
Soper DE; Brockwell NJ; Dalton HP
Contraception; 1991 Jul; 44(1):21-9. PubMed ID: 1893699
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
17. Clinical diagnosis of vaginal adenosis.
Stafl A; Mattingly RF; Foley DV; Fetherston WC
Obstet Gynecol; 1974 Jan; 43(1):118-28. PubMed ID: 4808952
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
19. Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Koetsawang S; Ji G; Krishna U; Cuadros A; Dhall GI; Wyss R; Rodriquez la Puenta J; Andrade AT; Khan T; Kononova ES
Contraception; 1990 Feb; 41(2):105-24. PubMed ID: 2107054
[TBL] [Abstract][Full Text] [Related]
20. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
